COMMUNIQUÉS West-GlobeNewswire

VALNEVA présentera sur Lyme et Zika au 18ème World Vaccine Congress de Washington, D.C.
29/03/2018
Valneva présentera sur Lyme et Zika au 18 ème World Vaccine Congress de Washington, D.C. Les présentations porteront sur les avancées cliniques des candidats vaccins contre la maladie de Lyme et le virus Zika Lyon ( [...]
Shire plc : Rule 2.9 Announcement
29/03/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 29 March 2018 [...]
Saniona AB: Change in number of shares and votes in Saniona AB (publ)
29/03/2018
PRESS RELEASE March 29, 2018 During March, the registered number of shares and votes in Saniona AB (publ) ("Saniona") has increased due to conversion of convertible notes issued pursuant to the convertible notes funding [...]
Shire Reports Regulatory Milestones for Investigational Hereditary Angioedema (HAE) Treatment Lanadelumab
29/03/2018
Shire Reports Regulatory Milestones for Investigational Hereditary Angioedema (HAE) Treatment Lanadelumab The European Medicines Agency (EMA) validates Shire's Marketing Authorization Application for investigational [...]
Herantis Pharma publishes an introductory video on its drug candidate CDNF for the treatment of Parkinson's disease
29/03/2018
Herantis Pharma publishes an introductory video on its drug candidate CDNF for the treatment of Parkinson's disease Herantis Pharma Plc Press release 29 March 2018 at 9:00 am Herantis Pharma Plc ("Herantis") has [...]
Sanofi: EMA to review sotagliflozin as potential treatment for type 1 diabetes
29/03/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) EMA to review sotagliflozin as potential treatment for type 1 diabetes Paris - March 29, 2018 - The European Medicines Agency (EMA) has accepted for review Sanofi [...]
Sanofi soumet à l'EMA le dossier de la sotagliflozine dans le traitement potentiel du diabète de type 1
29/03/2018
Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi soumet à l'EMA le dossier de la sotagliflozine dans le traitement potentiel du diabète de type 1 Paris - Le 29 mars 2018 - L'Agence européenne des [...]
Previously announced Tender Offers by Sanofi to acquire Ablynx will commence on April 4, 2018
29/03/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Source: Ablynx (Euronext Brussels and Nasdaq: ABLX) Previously announced Tender Offers by Sanofi to acquire Ablynx will commence on April 4, 2018 Prospectus [...]
Les Offres Publiques d'Acquisition annoncées précédemment par Sanofi en vue d'acquérir Ablynx seront lancées le 4 avril 2018
29/03/2018
Communiqué de presse Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Source: Ablynx (Euronext Brussels and Nasdaq: ABLX) Les Offres Publiques d'Acquisition annoncées précédemment par Sanofi en vue d'acquérir Ablynx seront [...]
PREVIOUSLY ANNOUNCED TENDER OFFERS BY SANOFI TO ACQUIRE ABLYNX WILL COMMENCE ON APRIL 4, 2018
29/03/2018
Prospectus approved by the FSMA on March 27, 2018 and to be published on April 3, 2018 Initial acceptance period will commence on April 4, 2018 and expire on May 4, 2018, subject to extension Paris, France and Ghent, [...]
MDxHealth (R): Denominator PR
29/03/2018
Press release Regulated information 29 March 2018, 7 a.m. CET MDxHealth's New Share Capital Amount and New Number of Shares IRVINE, CA, and HERSTAL, BELGIUM - 29 March 2018 - MDxHealth SA (Euronext Brussels: MDXH) (" [...]
MDxHealth (R) : Denominator PR
29/03/2018
C ommuniqué de presse Information réglementée 29 mars 2018, 7h00 HEC Nouveau Montant du Capital Social et Nouveau Nombre d'Actions de MDxHealth IRVINE, CA, et HERSTAL (BELGIQUE) - le 29 mars 2018 - MDxHealth SA ( [...]
Addex Sucessfully Raises CHF40 million in Capital Increase
29/03/2018
Geneva, Switzerland, 29 March 2018 - Addex Therapeutics (SIX: ADXN), the leading developer of oral allosteric modulators for neurological disorders, announced today that the company has successfully completed its [...]
Kiadis Pharma to announce Annual Results for the year ended December 31, 2017
29/03/2018
Kiadis Pharma to announce Annual Results for the year ended December 31, 2017 Amsterdam, The Netherlands, March 29, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS) , a [...]
Lexicon Pharmaceuticals Announces EMA Acceptance of Marketing Authorization Application (MAA) for Sotagliflozin to Treat Adults With Type 1 Diabetes
29/03/2018
THE WOODLANDS, Texas, March 29, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ), today announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA [...]
VIFOR PHARMA TO PROPOSE JACQUES THEURILLAT AS BOARD MEMBER
29/03/2018
Jacques Theurillat to be proposed to Annual Shareholder Meeting for appointment to Board Marc de Garidel will not stand for re-election All other members of the Board of Directors will stand for re-election VIFOR PHARMA [...]
Tower One Announces Extension of Warrant Incentive Program
29/03/2018
VANCOUVER, B.C., March 29, 2018 (GLOBE NEWSWIRE) -- Canada Tower One Wireless Corp (CSE:TO) (OTCMKTS:TOWTF) (Frankfurt: A2DKQ4 ) (“Tower One” or the “Company ”) announces, further to its news release dated January 9, [...]
Unum Therapeutics Announces Pricing of Initial Public Offering
29/03/2018
CAMBRIDGE, Mass., March 28, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX ) (“Unum Therapeutics”), a clinical-stage biopharmaceutical company focused on the development of novel immunotherapy products [...]
Sorrento Therapeutics Chairman/CEO update to stockholders
29/03/2018
SAN DIEGO, March 28, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE ) Dear Sorrento Stockholders, Despite a recent short seller opinion piece aimed at undermining the credibility of Sorrento and its [...]

Pages